Skip to content
The Nexus
DossierENTITY

right to try programs

Coverage of right to try programs in the Nexus archive.

Earliest in view: Jun 1 · 12:00 UTCMost recent: Jun 1 · 12:00 UTC
Co-mentioned in this coverage
Tomas Philipsonperson1Food and Drug Administrationorganization1The Multi-Trillion Dollar Opportunity in Reforming the FDAtopic1Chinaplace1Operation Warp Speedorganization1artificial intelligencetopic1
Recent coverage
  • HEALTHJun 1 · 12:00 UTCFOX NEWS
    FDA delays cost Americans trillions and slow lifesaving drugs, new report says

    A new report claims delaying Food and Drug Administration (FDA) reviews costs trillions in economic value and slows access to lifesaving drugs. The report estimates cutting FDA effectiveness-review timelines by one year could generate over $10 trillion in economic value by accelerating treatments and innovation. Proposed reforms include faster clinical trials, greater use of artificial intelligence, and expanded 'right to try' programs.

right to try programs · Dossier · The Nexus